Iomai

Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels

- HHS Now Reviewing Data to Determine Next Steps in $128 Million Contract - GAITHERSBURG, Md., March 20 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) today announced positive interim results from the 500-subject Phase 1/2 trial of its immunostimulant adjuvant patch used with an in...

Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT

...AITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today said that it wi...y's announcement that Intercell AG (VSE: ICLL) and iomai have entered into a definitive agreement pursuant to which Intercell will acquire iomai for USD 6.60 per share representing a fully dilute...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

... of the anthrax vaccine. Under the 1-year grant, iomai scientists will use vaccine antigen developed by U...ry version of antigen that can be combined with an iomai adjuvant on a needle-free patch. iomai will then evaluate the stability of the patch to d...

Iomai Reports 'Going Concern' Qualification in 10-K

...THERSBURG, Md., March 28 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced, in c... and filed on March 27, 2008 with the SEC. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...

Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17

...THERSBURG, Md., March 11 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ... software downloads that may be necessary. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...

Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch

...ITHERSBURG, Md., Feb. 12 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced the i...oint. "These results confirm our belief that the iomai patch can be effectively used by patients without ...us vaccine-related adverse events were reported. iomai is completing its Phase 2 program and plans to con...

Iomai Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study

...r. Glenn, Iomai's founder. "Those who received the iomai vaccination were much less likely to get sick, and... the University of Texas School of Public Health. iomai plans to begin a Phase 3 program for the needle-fr...a. Each volunteer received either two doses of the iomai vaccine patch or a placebo, 2 to 3 weeks apart, wi...

Bird-flu Vaccine Adjuvant Contract Goes to Novartis

...r firms were also awarded contracts on Wednesday by the U.S. Department of Health and Human Services. GlaxoSmithKline of England got $63.3 million and iomai of Maryland was given $14.4 million. The government expects the companies to intensify bird-flu vaccines by employing adjuvants. These increase ...

Skin-patch vaccines may replace injectable ones in future…

... A specialist in diarrheal diseases, he is helping iomai test the travelers' diarrhea patch in U.S. tourist...accine patches in 270 volunteers began last month. iomai is to conduct testing at a larger scale. "The...itors the patch project, although he cautions that iomai must prove if the immune booster works with a vari...

Iomai in Medical Technology

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

- Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully recommended share/cash transaction for USD 6.60 per share of Iomai's common stock representing a fully diluted equity value of Iomai of approximately USD 189 million (EUR 122 million). Acquisition to be accompli...

Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch

- Merck to Conduct Preclinical Proof-of-Principle Studies - GAITHERSBURG, Md., April 3, 2008 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) today announced that it has signed an agreement with Merck & Co., Inc. to conduct proof-of-principle preclinical studies evaluating th...

Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine

...VIENNA, Austria, June 11 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced the p...m 170 travelers, found that those who received the iomai patch-based vaccine were statistically significant...ction (p=0.033). "These results suggest that the iomai patch has the potential to fundamentally change th...

Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch

...THERSBURG, Md., April 15 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...pleted by Iomai. Guided by data from this study, iomai will begin a Phase 2 dose-ranging study designed t...stics of a mass vaccination program. Last month, iomai announced the results of the first clinical trial ...

Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5

...AITHERSBURG, Md., Nov. 2 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...y software downloads that may be necessary. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...

Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine

...al to Assess Safety and Dose-Sparing Capability of iomai Adjuvant Patch - ...ITHERSBURG, Md., Sept. 6 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...tion with an injected H5N1 influenza vaccine. The iomai patch, which contains a powerful immune-stimulatin...

Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC

...ITHERSBURG, Md., Aug. 23 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...hronic condition, irritable bowel syndrome. About iomai Corporation iomai Corporation discovers and develops vaccines and im...

Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine

...AITHERSBURG, Md., Aug. 9 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...he elderly. However, all subjects who received the iomai patch, regardless of age, seroconverted with IgG a...ai's transcutaneous immunization (TCI) approach." iomai last week announced that a Phase 2 field trial of ...

Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers' Diarrhea Stimulates Immune Response Even at Low Doses

...Portugal, April 26, 2007 /PRNewswire-FirstCall/ -- iomai Corporation today announced results from a 400-pat...hers found that even at the lowest dose tested, an iomai patch applied to the arm generated a robust respon...in the company's influenza patch programs. ABOUT iomai CORPORATION ...

Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow

...ssword-protected event management site. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...ns cells) to generate an enhanced immune response. iomai is leveraging TCI to enhance the efficacy of exist...

Iomai in Biological Technology

Novavax Appoints Stanley Erck to Board of Directors

...n twenty five years of experience in the biotechnology and health-care industries and served most recently as President and Chief Executive Officer of iomai Corporation, a developer of vaccines and immune system therapies that was acquired in 2008 by Intercell. Previously, Mr. Erck was President and Chief...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

...ompany's Board with over 20 years of experience in the biotechnology industry, most recently having served as President and Chief Executive Officer of iomai Corp. At Iomai, he led the company through an initial public offering, a merger with Intercell, an Austrian vaccine company, and through the developm...

Iomai Stockholders Approve Merger With Intercell Subsidiary

...AITHERSBURG, Md., Aug. 1 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) announced today that ... to be completed on or about Aug. 5, 2008. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...

Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today

...iego Convention Center. As previously announced, iomai and Intercell AG have entered into an agreement whereby iomai has agreed to be acquired by Intercell AG. About iomai Cooperation ...

Iomai Announces Year-End 2007 Financial Results and Business Progress

...ITHERSBURG, Md., March 6 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today reported financ...l Results For the full year ended Dec. 31, 2007, iomai reported a net loss available to common stockholde...ion, or $0.53 loss per share. As of Dec. 31, 2007, iomai had common stock outstanding of 25,588,673 shares....

Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6

...ITHERSBURG, Md., March 3 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ... password-protected event management site. About iomai Corporation iomai Corporation discovers and develops vaccines and im...

Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12

...AITHERSBURG, Md., Feb. 6 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ... software downloads that may be necessary. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...

Iomai to Announce Third Quarter 2007 Financial Results and Host Webcast on Tuesday, November 13

...AITHERSBURG, Md., Nov. 9 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...a password-protected event management site. About iomai Corporation iomai Corporation discovers and develops vaccines and im...

Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference

...N, South Africa, Oct. 11 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that iomai Chief Scientific Officer Gregory Glenn, M.D., pres... exceeding $750 million annually. If approved, the iomai vaccine would be the first vaccine for travelers' ...

Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday

...AITHERSBURG, Md., Oct. 5 /PRNewswire-FirstCall/ -- iomai Corporation (Nasdaq: IOMI ) today announced that ...y software downloads that may be necessary. ABOUT iomai CORPORATION iomai Corporation discovers and develops vaccines and im...